• Skip to Main Navigation
  • Skip to Search
  • Footer Area
USU | CHAMP sites:
  • HPRC
  • OPSS
Opss Logo
search icon
Opss Logo
Ask the Expert
search icon
  • left arrow INGREDIENTS and SUBSTANCES right arrow
    • DoD Prohibited List
    • Check Your Supplement Scorecard
    • Evaluating Name Brand Supplements
    • Report Adverse Effects
  • left arrow NEWS and ARTICLES right arrow
    • OPSS Library
    • Performance Enhancing Substances (PES)
    • News and Updates
  • left arrow RESOURCES and TRAINING right arrow
    • Outreach and Educational Materials
    • Train the Trainer
    • Apps
    • Newsletter
    • Trusted Partners and Government Resources
  • left arrow ABOUT right arrow
    • About Operation Supplement Safety (OPSS)
    • DoDI 6130.06: Use of Dietary Supplements in the DoD
Ask the Expert
USU | CHAMP sites:
  • HPRC
usu logoUSU logo
  • facebook iconFacebook
  • twitter iconTwitter
  • instagram iconInstagram
  • youtube iconYouTube

News and Updates

External links

All
  • All
  • DoD Prohibited List Updates
  • DoD and Military Policies
  • OPSS Outreach and Collaborations
  • OPSS Publications
  • Partner News
Sort By:
Newest
7 Results
July 29, 2025
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers

FDA continues to alert healthcare professionals and consumers about the risks of 7-hydroxymitragynine.

fda icon
July 15, 2025
FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine

FDA announced seven recent warning letters sent to companies for illegally marketing products containing 7-hydroxymitragynine, also known as 7-OH.

fda icon
July 9, 2025
FTC Sends Refunds to Consumers Harmed by Weight-loss Supplement Marketer’s Deceptive Claims and Review Practices

FTC is sending payments totaling more than $409,000 to consumers who purchased weight-loss supplements that were deceptively marketed.

ftc icon
April 29, 2025
OneOp Webinar: Dietary supplements, energy drinks, and Operation Supplement Safety (OPSS)

Professional development and education opportunity. 

instagram icon
April 22, 2025
FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products.

FDA has become aware of reports of adverse events involving compounded topical finasteride products.

fda icon
April 14, 2025
FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain

Patients should only obtain Ozempic with a valid prescription through state-licensed pharmacies, according to FDA. 

fda icon
October 16, 2024
Athlete Advisory: What’s New on the 2025 WADA Prohibited List?

Summary of changes to WADA Prohibited List

usada icon
  • instagram iconInstagram
  • twitter iconTwitter
  • facebook iconFacebook
  • youtube iconYouTube
NEWSLETTER
Opss Logo

Click here to sign up for the latest news on supplements and substances.

We will never share your email address with a third party for any reason, unless required to do so by law.
  • INGREDIENTS and SUBSTANCES down arrow up arrow
    • DoD Prohibited List
    • Check Your Supplement Scorecard
    • Evaluating Name Brand Supplements
    • Report Adverse Effects
  • NEWS and ARTICLES down arrow up arrow
    • OPSS Library
    • Performance Enhancing Substances (PES)
    • News and Updates
  • RESOURCES and TRAINING down arrow up arrow
    • Outreach and Educational Materials
    • Train the Trainer
    • Apps
    • Newsletter
    • Trusted Partners and Government Resources
  • ABOUT down arrow up arrow
    • About Operation Supplement Safety (OPSS)
    • DoDI 6130.06: Use of Dietary Supplements in the DoD
usu logoUSU logo
Back to Top